glp-1 drug prices A Heavy Price: The Economic and Social Costs of Weight Loss Drugs – Equilibrium – UW–Madison Medicare will negotiate Novo's GLP-1
Description
MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes

Nat Rev Endocrinol 8(12):728742 Davies MJ, Bain SC, Atkin SL, Rossing P, Scott D, Shamkhalova MS et al (2015) Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): a randomized clinical trial

Ligand biased was determined using the equiactive comparison as previously described 55

You'll start on a dose of 0.8 milligrams, but it also comes in doses of: 2.5 mg 5.5 mg 9 mg 14.5 mg 17.2 mg Approved for long-term use

This has knock-on implications for patent filings and life-cycle management of the small-molecules in this space
